Senior Manager, Accounting
Apply NowCompany: Avadel Management Corporation
Location: Chesterfield, MO 63017
Description:
About Avadel Pharmaceuticals plc
Who We Are: Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Oxybate therapy is currently the standard of care for the treatment of excessive daytime sleepiness (EDS) and cataplexy in patients living with narcolepsy. However, other approved oxybate products are immediate release formulations requiring two nightly doses - one dose at bedtime and the second dose 2.5-4 hours later, in the middle of the night. LUMRYZ TM (sodium oxybate) extended release for oral suspension, applies our proprietary drug delivery technology to allow for a single bedtime dose, eliminating the need to have a forced awakening during the middle of the night and giving patients the chance for an uninterrupted night's sleep. An extended-release medication sounds like a simple innovation, but it has been lacking for more than 20 years prior to our May 1, 2023 approval, and we believe this can be transformative for people with narcolepsy. For more information, please visit www.avadel.com or check out narcolespydisrupts.com.
What We Do: FDA-approved LUMRYZ (sodium oxybate) is a central nervous system depressant indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy. The FDA found LUMRYZ to be clinically superior to currently marketed twice-nightly oxybate products and granted LUMRYZ seven years of Orphan Drug Exclusivity for adults on May 1, 2023, and again for pediatric patients 7 years and older on October 16, 2024. In both instances, FDA found that LUMRYZ makes a major contribution to patient care over currently available, twice-nightly oxybate products by providing a once-nightly dosing regimen that avoids nocturnal awakening to take a second dose.
How We Work: At Avadel, patients are the reason we exist, and our employees are our greatest competitive advantage - our "secret sauce." The way we work is as important as the results we achieve. Our employees work together as ONE team and live our Values, which is what makes working at Avadel so special and why we will win for patients. Our ONE Team approach fosters a culture based on being relentless for patients, having confidence with humility, being courageous, taking insights to impact, and togetherness. In everything we do, we live the Avadel Values so we can be our best for our patients, our community and each other.
We need individuals who will dive in, roll up their sleeves, and join us to continue the LUMRYZ launch and our mission to serve the narcolepsy community.
Position Summary:
The Senior Accounting Manager will report to the Assistant Controller and will be a critical member of the finance team. We are looking for a Senior Accounting Manager who will be responsible for overseeing the day-to-day general ledger accounting operations, which will include cross-functional coordination. This position will participate in the preparation, support, review and completion of the monthly close accounting processes and internal reporting, as well as contributing to other public company financial reporting. Avadel offers a dynamic and fast-paced work environment, so the ability to learn and adapt quickly is essential.
Essential Functions:
Experience and Qualifications:
Competencies and Behaviors:
Avadel is committed to facilitating an open, honest, inclusive, transparent, and productive work environment where we work together as ONE team and ONE culture to be our best for patients, customers, and each other. Avadel is committed to equal employment opportunities and non-discrimination in employment. We believe that all employees and applicants should be treated with courtesy, dignity, and respect. Avadel does not discriminate in employment on the basis of race, color, religion, sex, sexual orientation, national origin, age, disability, genetic information, marital status, ancestry, gender, gender identity, pregnancy, status as a covered veteran, or any other characteristic protected by federal, state, and/or local law. It is our intent to comply with federal, state, and local laws, regulations, and guidelines in our employment practices and in our service to our clients. This policy applies to all terms and conditions of employment including, but not limited to, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation, and training.
Who We Are: Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Oxybate therapy is currently the standard of care for the treatment of excessive daytime sleepiness (EDS) and cataplexy in patients living with narcolepsy. However, other approved oxybate products are immediate release formulations requiring two nightly doses - one dose at bedtime and the second dose 2.5-4 hours later, in the middle of the night. LUMRYZ TM (sodium oxybate) extended release for oral suspension, applies our proprietary drug delivery technology to allow for a single bedtime dose, eliminating the need to have a forced awakening during the middle of the night and giving patients the chance for an uninterrupted night's sleep. An extended-release medication sounds like a simple innovation, but it has been lacking for more than 20 years prior to our May 1, 2023 approval, and we believe this can be transformative for people with narcolepsy. For more information, please visit www.avadel.com or check out narcolespydisrupts.com.
What We Do: FDA-approved LUMRYZ (sodium oxybate) is a central nervous system depressant indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy. The FDA found LUMRYZ to be clinically superior to currently marketed twice-nightly oxybate products and granted LUMRYZ seven years of Orphan Drug Exclusivity for adults on May 1, 2023, and again for pediatric patients 7 years and older on October 16, 2024. In both instances, FDA found that LUMRYZ makes a major contribution to patient care over currently available, twice-nightly oxybate products by providing a once-nightly dosing regimen that avoids nocturnal awakening to take a second dose.
How We Work: At Avadel, patients are the reason we exist, and our employees are our greatest competitive advantage - our "secret sauce." The way we work is as important as the results we achieve. Our employees work together as ONE team and live our Values, which is what makes working at Avadel so special and why we will win for patients. Our ONE Team approach fosters a culture based on being relentless for patients, having confidence with humility, being courageous, taking insights to impact, and togetherness. In everything we do, we live the Avadel Values so we can be our best for our patients, our community and each other.
We need individuals who will dive in, roll up their sleeves, and join us to continue the LUMRYZ launch and our mission to serve the narcolepsy community.
Position Summary:
The Senior Accounting Manager will report to the Assistant Controller and will be a critical member of the finance team. We are looking for a Senior Accounting Manager who will be responsible for overseeing the day-to-day general ledger accounting operations, which will include cross-functional coordination. This position will participate in the preparation, support, review and completion of the monthly close accounting processes and internal reporting, as well as contributing to other public company financial reporting. Avadel offers a dynamic and fast-paced work environment, so the ability to learn and adapt quickly is essential.
Essential Functions:
- Provide guidance and support to a team of senior accountants to achieve high levels of productivity by establishing objectives and managing priorities.
- Lead team in the month, quarter and year end close process.
- Evaluation and approval of journal entries and monthly balance sheet reconciliations for appropriate support and accuracy - reviewing variances with team to determine error correction.
- Review monthly Balance Sheet reconciliations for appropriate support and accuracy.
- Collaborate with various departments (HR, Legal, Operations, Supply Chain).
- Maintain a strong process driven environment, ensuring controls are in place and operating effectively.
- Ensure appropriate internal control documentation.
- Assist with annual external and internal audit processes.
- Ad hoc projects and analysis as needed.
Experience and Qualifications:
- Bachelor's degree in Accounting
- 7+ years of experience in public and/or industry accounting sector
- 2+ years of managerial experience supervising direct reports
- CPA certification preferred (current)
- Strong understanding of US GAAP
- Proficient in Excel and Microsoft Office Suite
- Experience with SAGE X12 ERP a plus
Competencies and Behaviors:
- Excellent attention to details and accuracy.
- Ability to lead a team and demonstrate strong leadership skills and fostering open communication.
- Excellent verbal and written communication skills.
- Ability to fully own projects from execution through to completion and documentation.
- Strong time-management and prioritization skills, with an emphasis on managing deadlines.
- Ability to work independently while understanding the necessity for communicating and coordinating work efforts with other employees and departments.
- Ability to appropriately handle confidential information.
- Flexibility in a Hybrid work environment.
Avadel is committed to facilitating an open, honest, inclusive, transparent, and productive work environment where we work together as ONE team and ONE culture to be our best for patients, customers, and each other. Avadel is committed to equal employment opportunities and non-discrimination in employment. We believe that all employees and applicants should be treated with courtesy, dignity, and respect. Avadel does not discriminate in employment on the basis of race, color, religion, sex, sexual orientation, national origin, age, disability, genetic information, marital status, ancestry, gender, gender identity, pregnancy, status as a covered veteran, or any other characteristic protected by federal, state, and/or local law. It is our intent to comply with federal, state, and local laws, regulations, and guidelines in our employment practices and in our service to our clients. This policy applies to all terms and conditions of employment including, but not limited to, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation, and training.